Acute myeloid leukemia: open trials in Romania

10 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

NCT05429632
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Trial Treatment · Phase 3 · Priothera SAS
Institutul Clinic Fundeni, Bucharest · Spitalul Clinic Colțea, Bucharest · Institutul Regional de Oncologie Iasi, - Haematology Department, Iași
Registry updated 2026-10-30
NCT07504458
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Trial Treatment · Phase 3 · Quetzal Therapeutics
Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca
Registry updated 2026-10-30
NCT06459024
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
Research · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Fundeni Clinical Institute, Bucharest
Registry updated 2026-10-27
NCT06713837
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Trial Treatment · Phase 3 · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Institutul Clinic Fundeni, Bucharest
Registry updated 2026-10-27
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Spitalul Clinic Colțea, Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Institutul Regional de Oncologie Iasi, Iași · Spitalul Clinic Judetean de Urgenta Targu Mures, Târgu Mureş · Spitalul Clinic Municipal de Urgenta Timisoara - Hematology, Timisoara
Registry updated 2026-10-21
NCT06788756
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Trial Treatment · Phase 2/3 · Moleculin Biotech, Inc.
Coltea Clinical Hospital, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Spitalul Clinic Municipal De Urgenta Timisoara, Timisoara
Registry updated 2026-08-05
NCT04093570
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Trial Treatment · Phase 2 · Taiho Oncology, Inc.
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-07-28
NCT04953897
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-05-28
NCT04953910
Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-05-28
NCT05907057
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Trial Treatment · Phase 3 · Servier Affaires Médicales
Institutul Clinic Fundeni, Bucharest · Spitalul Universitar de Urgență București, Bucharest · Spitalul Clinic Colțea, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca
Registry updated 2026-05-08

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error